Elyns Journal of Pharmaceutical Research

Editor in Chief

Dr. Mohamed Salama has completed his Ph. D in Pharmaceutics from the Institute of pharmacy and pharmaceutical chemistry, Leningrad (Saint Petersburg), Russia in (1975). He received many awards and honors. He is a member of the management committee of Faculty of Pharmacy. Currently he is working as a Professor of pharmaceutics, Faculty of Pharmacy, UiTM, Malaysia. 

 

Name : Mohamed Salama
University : Faculty of Pharmacy, UiTM

Indexing and Listing



Recent Articles

  • article image

    Qbd in Developing Topical Dosage Forms

    In pharmaceutical industry the quality by testing (QbT) system is used to ensure the drug product quality which is an unbending process with its bound specifications for manufactured batches. Flexibility is limited as change at every stage requires submission of a supplement with respect to change to the USFDA (United States Food and Drug Administration).…

    View more
  • article image

    Pharmaceutical Nanotechnology: Past, Present and Future

    The nanotechnology, which is the creation of materials at the nanometer scale, is in fact key area in science and technology which has been extensively explored during the last decades and represents one of the most important directions in the technological developments of the leading countries in the 21st Century. Particularly in the field of drug…

    View more
  • article image

    Nanopharmaceuticals: The Pharmaceuticals of the Present Era

    Nanopharmaceutics shelter all aspects of nanotechnology based pharmaceutics that applies to formulation, development and delivery aspects of pharmaceuticals. Nanomaterials (nano size materials) that bring unique shapes and functionalities and nanodevices show a strategic role in pharmaceutical nanotechnology. Nanopharmaceutics is the hope of healthcare…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial